Title 12, TITLE 12. HUMAN SERVICES
337 chapters · 3,371 sections in this title.
Ind. Code § 12-15-35.5-1 Applicability
0.2K chars
Sec. 1. This chapter applies to: (1) the Medicaid program under this article; and (2) the children's health insurance program under IC 12-17.6. As added by P.L.6-2002, SEC.4. Amended by P.L.101-2005, SEC.5.
Ind. Code § 12-15-35.5-2 "Cross-indicated drug" defined
0.3K chars
Sec. 2. As used in this chapter, "cross-indicated drug" means a drug that is used for a purpose generally held to be reasonable, appropriate, and within the community standards of practice even though the use is not included in the federal Food and Drug Administration's approved …
Ind. Code § 12-15-35.5-2.5 "Unrestricted access" defined
0.3K chars
Sec. 2.5. As used in this chapter, "unrestricted access" means the ability of a recipient to obtain a prescribed drug without being subject to limits or preferences imposed by the office or the board for the purpose of cost savings except as provided under section 7 of this chapt…
Ind. Code § 12-15-35.5-2.6 "Waste"
0.3K chars
Sec. 2.6. As used in this chapter, "waste" means inappropriate: (1) overprescribing; (2) underprescribing; (3) overutilization; (4) underutilization; (5) recipient noncompliance with the prescribed regimen; or (6) clinically unjustified utilization; of a prescription drug. As add…
Ind. Code § 12-15-35.5-3 Prohibition on prior authorization of mental health drugs;
2.1K chars
exception Sec. 3. (a) Except as provided in subsection (b), the office may establish prior authorization requirements for drugs covered under a program described in section 1 of this chapter. (b) With the exception of prior authorization for "brand medically necessary" of a brand…
Ind. Code § 12-15-35.5-4 Prior authorization requirement parameters
0.6K chars
Sec. 4. Prior authorization requirements developed under this chapter must: (1) comply with all applicable state and federal laws, including the provisions of 405 IAC 5-3 and 42 U.S.C. 1396r-8(d)(5); and (2) provide that the prior authorization number assigned to an approved requ…
Ind. Code § 12-15-35.5-5 Prior authorization procedures
0.2K chars
Sec. 5. Before requiring prior authorization for a single source drug, the office shall seek the advice of the drug utilization review board, established by IC 12-15-35-19, at a public meeting of the board. As added by P.L.6-2002, SEC.4.
Ind. Code § 12-15-35.5-6 Publication of prior authorization decision
0.2K chars
Sec. 6. (a) The office shall publish the decision to require prior authorization for a single source drug in a provider bulletin. (b) IC 12-15-13-6 applies to a provider bulletin described in subsection (a). As added by P.L.6-2002, SEC.4.
Ind. Code § 12-15-35.5-7 Limitations on drug refills; limitations on restrictions on
5.0K chars
certain mental health drugs Sec. 7. (a) Subject to subsections (b) and (c), the office may place limits on quantities dispensed or the frequency of refills for any covered drug as required by law or for the purpose of: (1) preventing fraud, abuse, or waste; (2) preventing overuti…
Ind. Code § 12-15-35.5-7.5 Reimbursement for methadone when prescribed for pain;
0.9K chars
requirements Sec. 7.5. (a) The office may reimburse under Medicaid for methadone if the drug was prescribed for the treatment of pain or pain management only as follows: (1) If the daily dosage is not more than sixty (60) milligrams. (2) If the daily dosage is more than sixty (60…
Ind. Code § 12-15-35.5-8 Restriction of mental health drugs for individuals less than 18
0.4K chars
years of age Sec. 8. In addition to the limits described in section 7 of this chapter, the office may restrict a mental health drug described in section 3 of this chapter that is prescribed for an individual who is less than eighteen (18) years of age if federal financial partici…
Ind. Code § 12-15-35.5-9 Reimbursement for drugs indicated only for addiction
0.3K chars
treatment Sec. 9. The office may not reimburse under Medicaid for Subutex, Suboxone, or a similar trade name or generic of the drug if the drug is only indicated for addiction treatment and was prescribed for the treatment of pain or pain management. As added by P.L.37-2016, SEC.…